Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-056261

Chief Scientific Officer sold 11,685 shares at an average $36.98 ($432,054)

  • Chief Scientific Officer acquired 11,685 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBINS HARLAN S · Chief Scientific Officer

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-13 Exercise or conversion : show line 1 in the form +3,895 $6.32 $24,616 73,255 D
2021-09-13 Sale : show line 2 in the form −2,995 $37.39 $111,983 70,260 D
2021-09-13 Sale : show line 3 in the form −900 $37.89 $34,101 69,360 D
2021-09-14 Exercise or conversion : show line 4 in the form +3,895 $6.32 $24,616 73,255 D
2021-09-14 Sale : show line 5 in the form −2,795 $36.49 $101,990 70,460 D
2021-09-14 Sale : show line 6 in the form −1,100 $37.36 $41,096 69,360 D
2021-09-15 Exercise or conversion : show line 7 in the form +3,895 $6.32 $24,616 73,255 D
2021-09-15 Sale : show line 8 in the form −2,995 $36.52 $109,377 70,260 D
2021-09-15 Sale : show line 9 in the form −900 $37.23 $33,507 69,360 D
Open-market sales · 11,685 sh · avg $36.98 · $432,054

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-09-13 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −3,895 89,585 D
2021-09-14 Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) −3,895 85,690 D
2021-09-15 Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) −3,895 81,795 D
Loading xslF345X03/doc4.xml…